Cargando…

Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study

BACKGROUND & OBJECTIVES: It is well known that cognitive impairment in patients with chronic kidney disease (CKD) is characterized by executive dysfunction, rather than memory dysfunction, although the precise mechanism of this remains to be elucidated. The purpose of the present study is to exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuruya, Kazuhiko, Yoshida, Hisako, Haruyama, Naoki, Fujisaki, Kiichiro, Hirakata, Hideki, Kitazono, Takanari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669129/
https://www.ncbi.nlm.nih.gov/pubmed/26632813
http://dx.doi.org/10.1371/journal.pone.0143706
_version_ 1782404066427535360
author Tsuruya, Kazuhiko
Yoshida, Hisako
Haruyama, Naoki
Fujisaki, Kiichiro
Hirakata, Hideki
Kitazono, Takanari
author_facet Tsuruya, Kazuhiko
Yoshida, Hisako
Haruyama, Naoki
Fujisaki, Kiichiro
Hirakata, Hideki
Kitazono, Takanari
author_sort Tsuruya, Kazuhiko
collection PubMed
description BACKGROUND & OBJECTIVES: It is well known that cognitive impairment in patients with chronic kidney disease (CKD) is characterized by executive dysfunction, rather than memory dysfunction, although the precise mechanism of this remains to be elucidated. The purpose of the present study is to examine the correlation between gray matter volume (GMV) and executive function in CKD patients. DESIGN, SETTING, PARTICIPANTS, MEASUREMENTS: This cross-sectional study recruited 95 patients with non-dialysis-dependent CKD (NDD-CKD) with no history of cerebrovascular disease, who underwent brain magnetic resonance imaging (MRI) and Trail Making Test (TMT) in the VCOHP Study. The subjects underwent brain MRI and TMT part A (TMT-A) and part B (TMT-B). The segmentation algorithm from Statistical Parametric Mapping 8 software was applied to every T1-weighted MRI scan to extract tissue maps corresponding to gray matter, white matter, and cerebrospinal fluid. GMV was normalized by dividing by the total intracranial volume, calculated by adding GMV, white matter volume, and cerebrospinal fluid space volume. Then, normalized whole-brain GMV was divided into four categories of brain lobes; frontal, parietal, temporal, and occipital. We assessed the correlation between normalized GMV and TMT using multivariable regression analysis. RESULTS: Normalized whole-brain GMV was significantly inversely correlated to the scores of TMT-A, TMT-B, and ΔTMT (TMT-B minus TMT-A). These correlations remained significant even after adjusting for relevant confounding factors. Normalized frontal and temporal GMV, but not parietal and occipital GMV, were significantly inversely correlated with TMT-A, TMT-B, and ΔTMT using multivariable regression analysis. CONCLUSIONS: The present study demonstrates the correlation between normalized GMV, especially in the frontal and temporal lobes, and executive function, suggesting that fronto-temporal gray matter atrophy might contribute to executive dysfunction in NDD-CKD.
format Online
Article
Text
id pubmed-4669129
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46691292015-12-10 Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study Tsuruya, Kazuhiko Yoshida, Hisako Haruyama, Naoki Fujisaki, Kiichiro Hirakata, Hideki Kitazono, Takanari PLoS One Research Article BACKGROUND & OBJECTIVES: It is well known that cognitive impairment in patients with chronic kidney disease (CKD) is characterized by executive dysfunction, rather than memory dysfunction, although the precise mechanism of this remains to be elucidated. The purpose of the present study is to examine the correlation between gray matter volume (GMV) and executive function in CKD patients. DESIGN, SETTING, PARTICIPANTS, MEASUREMENTS: This cross-sectional study recruited 95 patients with non-dialysis-dependent CKD (NDD-CKD) with no history of cerebrovascular disease, who underwent brain magnetic resonance imaging (MRI) and Trail Making Test (TMT) in the VCOHP Study. The subjects underwent brain MRI and TMT part A (TMT-A) and part B (TMT-B). The segmentation algorithm from Statistical Parametric Mapping 8 software was applied to every T1-weighted MRI scan to extract tissue maps corresponding to gray matter, white matter, and cerebrospinal fluid. GMV was normalized by dividing by the total intracranial volume, calculated by adding GMV, white matter volume, and cerebrospinal fluid space volume. Then, normalized whole-brain GMV was divided into four categories of brain lobes; frontal, parietal, temporal, and occipital. We assessed the correlation between normalized GMV and TMT using multivariable regression analysis. RESULTS: Normalized whole-brain GMV was significantly inversely correlated to the scores of TMT-A, TMT-B, and ΔTMT (TMT-B minus TMT-A). These correlations remained significant even after adjusting for relevant confounding factors. Normalized frontal and temporal GMV, but not parietal and occipital GMV, were significantly inversely correlated with TMT-A, TMT-B, and ΔTMT using multivariable regression analysis. CONCLUSIONS: The present study demonstrates the correlation between normalized GMV, especially in the frontal and temporal lobes, and executive function, suggesting that fronto-temporal gray matter atrophy might contribute to executive dysfunction in NDD-CKD. Public Library of Science 2015-12-03 /pmc/articles/PMC4669129/ /pubmed/26632813 http://dx.doi.org/10.1371/journal.pone.0143706 Text en © 2015 Tsuruya et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Tsuruya, Kazuhiko
Yoshida, Hisako
Haruyama, Naoki
Fujisaki, Kiichiro
Hirakata, Hideki
Kitazono, Takanari
Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study
title Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study
title_full Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study
title_fullStr Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study
title_full_unstemmed Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study
title_short Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study
title_sort clinical significance of fronto-temporal gray matter atrophy in executive dysfunction in patients with chronic kidney disease: the vcohp study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669129/
https://www.ncbi.nlm.nih.gov/pubmed/26632813
http://dx.doi.org/10.1371/journal.pone.0143706
work_keys_str_mv AT tsuruyakazuhiko clinicalsignificanceoffrontotemporalgraymatteratrophyinexecutivedysfunctioninpatientswithchronickidneydiseasethevcohpstudy
AT yoshidahisako clinicalsignificanceoffrontotemporalgraymatteratrophyinexecutivedysfunctioninpatientswithchronickidneydiseasethevcohpstudy
AT haruyamanaoki clinicalsignificanceoffrontotemporalgraymatteratrophyinexecutivedysfunctioninpatientswithchronickidneydiseasethevcohpstudy
AT fujisakikiichiro clinicalsignificanceoffrontotemporalgraymatteratrophyinexecutivedysfunctioninpatientswithchronickidneydiseasethevcohpstudy
AT hirakatahideki clinicalsignificanceoffrontotemporalgraymatteratrophyinexecutivedysfunctioninpatientswithchronickidneydiseasethevcohpstudy
AT kitazonotakanari clinicalsignificanceoffrontotemporalgraymatteratrophyinexecutivedysfunctioninpatientswithchronickidneydiseasethevcohpstudy